PATEL DINESH V PH D 4
4 · Protagonist Therapeutics, Inc · Filed Jul 23, 2025
Insider Transaction Report
Form 4
PATEL DINESH V PH D
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-07-22$55.05/sh−22,065$1,214,678→ 548,538 total - Award
Common Stock
2025-07-21+25,000→ 583,462 total - Sale
Common Stock
2025-07-21$54.86/sh−12,859$705,445→ 570,603 total - Sale
Common Stock
2025-07-23$54.79/sh−17,520$959,921→ 531,018 total
Footnotes (4)
- [F1]Represents settlement by the Issuer of performance stock units ("PSUs") granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan on February 26, 2021, which vested based on the Issuer's achievement of corporate performance objectives.
- [F2]Sale of shares to cover tax withholding obligation incurred upon settlement of PSUs.
- [F3]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.00 to $55.19. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F4]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $54.75 to $55.00. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.